Kumulus Vape [ALVAP] vs Cnova N.V [CNV] Detailed Stock Comparison
Kumulus Vape
Euronext
Loading...
Cnova N.V
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Kumulus Vape wins in 10 metrics, Cnova N.V wins in 6 metrics, with 0 ties. Kumulus Vape appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Kumulus Vape | Cnova N.V | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 5.22 | -0.34 | Cnova N.V |
| Price-to-Book Ratio | 0.87 | -0.06 | Cnova N.V |
| Debt-to-Equity Ratio | 25.20 | -1.32 | Cnova N.V |
| PEG Ratio | N/A | 0.01 | N/A |
| EV/EBITDA | 3.10 | 17.41 | Kumulus Vape |
| Profit Margin (TTM) | 4.35% | -9.06% | Kumulus Vape |
| Operating Margin (TTM) | 5.87% | -0.40% | Kumulus Vape |
| EBITDA Margin (TTM) | 5.87% | N/A | N/A |
| Return on Equity | 17.19% | 15.61% | Kumulus Vape |
| Return on Assets (TTM) | 8.59% | -1.53% | Kumulus Vape |
| Free Cash Flow (TTM) | $-429,000 | $-30.90M | Kumulus Vape |
| Dividend Yield | 3.68% | N/A | N/A |
| 1-Year Return | -27.69% | -95.91% | Kumulus Vape |
| Price-to-Sales Ratio (TTM) | 0.24 | 0.03 | Cnova N.V |
| Enterprise Value | $12.94M | $879.30M | Cnova N.V |
| EV/Revenue Ratio | 0.21 | 0.85 | Kumulus Vape |
| Gross Profit Margin (TTM) | N/A | 12.89% | N/A |
| Revenue per Share (TTM) | $20 | $3 | Kumulus Vape |
| Earnings per Share (Diluted) | $0.90 | $-0.27 | Kumulus Vape |
| Beta (Stock Volatility) | 1.21 | 1.03 | Cnova N.V |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Kumulus Vape vs Cnova N.V Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Kumulus Vape | 0.00% | 2.17% | -4.08% | -4.86% | -8.56% | -11.32% |
| Cnova N.V | 0.22% | 0.00% | 0.00% | -25.00% | -47.06% | -40.00% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Kumulus Vape | -27.69% | -51.14% | -14.55% | 104.35% | 104.35% | 104.35% |
| Cnova N.V | -95.91% | -97.93% | -97.32% | -98.18% | -98.36% | -98.36% |
Performance & Financial Health Analysis: Kumulus Vape vs Cnova N.V
| Metric | ALVAP | CNV |
|---|---|---|
| Market Information | ||
| Market Cap | €14.45M | €32.17M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,412 | 804 |
| 90 Day Avg. Volume | 2,397 | 335 |
| Last Close | €4.70 | €0.09 |
| 52 Week Range | €3.90 - €7.60 | €0.09 - €3.00 |
| % from 52W High | -38.16% | -96.89% |
| All-Time High | €15.90 (May 10, 2021) | €12.50 (Jun 07, 2021) |
| % from All-Time High | -70.44% | -99.28% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.04% | -0.07% |
| Quarterly Earnings Growth | 1.17% | -0.36% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | -0.09% |
| Operating Margin (TTM) | 0.06% | 0.00% |
| Return on Equity (TTM) | 0.17% | 0.16% |
| Debt to Equity (MRQ) | 25.20 | -1.32 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €5.38 | €-1.94 |
| Cash per Share (MRQ) | €1.83 | €0.04 |
| Operating Cash Flow (TTM) | €-1,099,032 | €25.61M |
| Levered Free Cash Flow (TTM) | €-1,013,458 | €-35,768,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.68% | N/A |
| Last 12-Month Dividend | €0.17 | N/A |
Valuation & Enterprise Metrics Analysis: Kumulus Vape vs Cnova N.V
| Metric | ALVAP | CNV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 5.22 | -0.34 |
| Forward P/E | 4.61 | N/A |
| PEG Ratio | N/A | 0.01 |
| Price to Sales (TTM) | 0.24 | 0.03 |
| Price to Book (MRQ) | 0.87 | -0.06 |
| Market Capitalization | ||
| Market Capitalization | €14.45M | €32.17M |
| Enterprise Value | €12.94M | €879.30M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.21 | 0.85 |
| Enterprise to EBITDA | 3.10 | 17.41 |
| Risk & Other Metrics | ||
| Beta | 1.21 | 1.03 |
| Book Value per Share (MRQ) | €5.38 | €-1.94 |
Financial Statements Comparison: Kumulus Vape vs Cnova N.V
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALVAP | CNV |
|---|---|---|
| Revenue/Sales | N/A | €584.10M |
| Cost of Goods Sold | N/A | €508.80M |
| Gross Profit | N/A | €75.30M |
| Research & Development | N/A | €15.50M |
| Operating Income (EBIT) | N/A | €1.30M |
| EBITDA | N/A | €11.50M |
| Pre-Tax Income | N/A | €-8.80M |
| Income Tax | N/A | €10.50M |
| Net Income (Profit) | N/A | €321.80M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALVAP | CNV |
|---|---|---|
| Cash & Equivalents | €5.20M | €14.81M |
| Total Current Assets | €22.35M | €331.37M |
| Total Current Liabilities | €6.00M | €521.63M |
| Long-Term Debt | €3.00M | €733.04M |
| Total Shareholders Equity | €17.24M | €-603.19M |
| Retained Earnings | €2.75M | €-1.13B |
| Property, Plant & Equipment | €204,972 | €0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALVAP | CNV |
|---|---|---|
| Operating Cash Flow | N/A | €-16.80M |
| Capital Expenditures | N/A | €-20.20M |
| Free Cash Flow | N/A | €-51.10M |
| Debt Repayment | N/A | €-493.60M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALVAP | CNV |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 3,412 | 804 |
| Average Daily Volume (90 Day) | 2,397 | 335 |
| Shares Outstanding | 3.06M | 345.21M |
| Float Shares | N/A | 1.22M |
| % Held by Insiders | 0.37% | 0.99% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Kumulus Vape vs Cnova N.V
| Metric | ALVAP | CNV |
|---|---|---|
| Last 12-Month Dividend | €0.17 | N/A |
| Last 12-Month Dividend Yield | 3.68% | N/A |
| 3-Year Avg Annual Dividend | €0.14 | N/A |
| 3-Year Avg Dividend Yield | 2.48% | N/A |
| 3-Year Total Dividends | €0.42 | N/A |
| Ex-Dividend Date | Jun 26, 2025 | N/A |